|
Zolotovskaya I.A., Shatskaya P.R.
Secondary prevention of deep vein thrombosis: current approaches, efficacy and safety
|
10-15 |
|
Khalilov M.A., Moshkin A.S., Moshkina L.V., Shmeleva S.V., Tuzov I.N., Belyakova N.V., Khromov S.E.
The impact of individual characteristics of the carotid arteries and heart on disease development
|
16-21 |
|
Izmozherova N.V., Shambatov M.A., Erlish D.S., Kolnogorova Ya.R.
Deprescribing challenges in elderly patients at high cardiovascular risk
|
22-28 |
|
Vydashenko A.V., Elagin D.V., Sheremet M.I.
Goflikicept: a new promising drug for the treatment of recurrent pericarditis
|
30-34 |
GASTROENTEROLOGY / HEPATOLOGY |
|
Trukhan D.I., Rozhkova M.Yu., Goloshubina V.V., Shuganova P.V.
The use of natural mineral water Donat for functional gastrointestinal disorders in comorbid patients: connective tissue dysplasia is in focus
|
35-42 |
|
Nikitin I.G., Danilov A.B., Poromov A.A., Yankovaya T.N., Rybnikova I.D., Mikhailova O.V., Chuprakova N.O., Kudryavtseva A.P., Yunusova O.V., Makarova N.V., Shavalieva L.P., Demidova L.I., Kozlov V.I., Karimullina F.M., Fazylova Z.R.
Efficacy and safety of the drug Phosphogliv® URSO in patients with indications for oral litholysis: cholelithiasis and the pre-stone stage of the disease
|
43-54 |
PULMONOLOGY / INFECTIOUS DISEASES |
|
Trushina E.Yu., Kostina E.M., Tipikin V.A., Illarinov I.I., Orlova E.A., Turovskaya A.A.
Genetically engineered biological therapy of severe bronchial asthma with benralizumab
|
55-60 |
|
Mordyk A.V., Romanova M.A., Bagisheva N.V., Shapran A.A., Tretyakov G.V., Kolpakova T.A.
The contribution of immunodiagnostics to the detection of tuberculosis in adults from a rural tuberculosis infection foci
|
62-68 |
|
Pritulina Yu.G., Gankovskaya L.V., Babenkova D.V.
Clinical efficacy of combination antiviral therapy in patients with Herpes zoster
|
70-77 |
|
Mostovoi A.V., Karpova A.L., Burenkov R.A, Ermoolinsky P.B., Lugovtsov A.E., Vorobyeva S.V., Sinitsa D.R., Igina I.M., Nekhoroshkin S.A., Volodin N.N.
Physical properties of surfactant as a basis for its effectiveness in the experiment
|
78-87 |
|
|
Zyryanov S.K., Bondarev A.V.
Current clinical and pharmacoeconomic aspects of osteoarthritis therapy
|
88-96 |
|
Polischuk E.Yu., Khlaboshchina V.N., Karateev A.E., Makarov M.A., Filatova E.S., Lila A.M.
Clinical features of patients with rheumatoid arthritis requiring knee and hip arthroplasty depending on disease activity
|
97-102 |
|
Babak S.L., Gorbunova M.V., Malyavin A.G.
Acute insomnia and clinical strategy of risk modification in patients with chronic non-communicable diseases
|
104-112 |
|
Serdyuk A.V.
In search of the “gold standard” for the treatment of post-stroke upper limb spasticity
|
113-119 |
|
Filatova E.G.
Chronic migraine: diagnosis and treatment
|
120-127 |
|
Nikolaev V.M., Mestnikova V.N., Krasnova N.M., Asekritova A.S., Tatarinova O.V., Sychev D.A.
Comparative levels of microRNA expression (hsa-miR-29c and hsa-miR-19b) in the blood of patients with Alzheimer’s disease and healthy individuals: biomarker potential
|
128-134 |
|
Gorban V.V., Manto V.S., Kornienko A.S., Andreychenko A.E., Namitokova R.Z.
The impact of night shift work of medical students on their psychoemotional state and autonomic nervous system
|
135-141 |
DERMATOLOGY / ALLERGOLOGY |
|
Yusupova L.A., Khasanov R.Sh., Karpenko L.G., Gataullin I.G., Afanasieva Z.A.
Skin melanoma: causes and main treatment approaches
|
143-150 |
|
Kandrashkina Yu.A., Orlova E.A.
Characteristics of clinical phenotypes of atopic dermatitis in pregnant women
|
151-156 |
|
|
Kuzina S.V., Silantyeva E.S., Ovchinnikova M.M., Kutakova Yu.Yu.
Efficiency of human placenta extract as a subcutaneous injection in patients with uterine factor of infertility in ART programs
|
157-165 |
Oncology |
|
Shaikhelislamova L.F., Lazakovich A.A., Vats A.B., Akhmedov R.M., Zhurov A.S., Zueva D.S., Belousov A.M., Dashyan G.A.
Aromatase inhibitor-associated arthralgia in breast cancer: etiopathogenesis and treatment
|
166-172 |
|
Beliak N.P., Kutukova S.I., Smirnova N.V., Androsova A.V., Mgar E.A., Varankina A.A., Ksanaeva L.A., Pelipas Yu. V., Orlova R.V.
Prognostic value of regional lymph node status in locally advanced gastric cancer after neoadjuvant treatment
|
174-181 |
|
Khaitovich E.D., Shikh E.V., Ibragimov A.N., Gergel M.A., Borisov A.S., Kazakov R.E.
Genetic variations of morphine transporters: prevalence of polymorphisms of the ABCB1 gene among oncology patients of palliative profile
|
182-188 |
|
Stepanova Ya.L., Klemenova I.A., Garanina O.E., Mironycheva A.M., Uskova K.A., Makarova S.S., Shlivko I.L.
Clinical efficacy of La Roche-Posay dermatological laboratory products in the treatment of dermatological toxicity associated with anticancer therapy: results of a prospective study
|
190-197 |
|
Natalenko S.A., Orlova R.V., Belyak N.P., Kutukova S.I., Ksanaeva L.A.
Oxaliplatin-induced peripheral neuropathy as a factor influencing the efficacy of the mFOLFOX6 regimen in patients with metastatic colorectal cancer: a retrospective study
|
198-207 |
|
Ermakova T.S., Topuzov E.E., Kutukova S.I., Ershov V.A.
Predicting the recurrence of basal cell carcinoma of the scalp
|
208-212 |
|
Khakimova G.G., Reshetov I.V., Zikiryakhodjaev A.D., Khakimova Sh.G.
Quality of life of patients with early breast cancer with and without sentinel lymph node biopsy
|
213-218 |
|
Orlova R.V., Gorkina Ya.R., Protasova A.E., Molchanov S.V., Krotov M.Yu.
Analysis of socio-demographic and clinical-morphological characteristics of recurrent and metastatic cervical cancer
|
220-226 |
|
https://dx.doi.org/10.18565/pharmateca.2025.6.227-232
A clinical case of the effectiveness of chemo-targeted therapy in the first line of treatment for recurrent squamous cell carcinoma of the larynx
|
227-232 |
ALGORITHMS |
|
Maev I.V., Yurenev G.L., Andreev D.N., Ovsepyan M.A., Barkalova E.V.
Algorithms for diagnosis and treatment of gastroesophageal reflux disease
|
233-247 |
|
Kotova O.V., Belyaeva A.A., Lebedeva D.I.
Musculoskeletal (non-specific) lower back pain: diagnosis and treatment
|
248-256 |
|
Erofeeva S.B.
Acute tonsillitis and pharyngitis (tonsilopharyngitis) in adults and children. Diagnostic and treatment algorithm
|
257-268 |
|
Shavlovskaya O.A.
Clinical application areas and regimens Recognan (citicoline) treatment in neurology
|
269-275 |
Comorbidity |
|
Streltsova V.V., Antipova E.P., Mordyk A.V., Bagisheva N.V., Moiseeva M.V., Viktorova I.A.
New coronavirus infection in patients with chronic heart failure: clinical features in different periods of the pandemic
|
276-281 |
|
Dukhanina E.S., Enkova E.V., Obernikhin K.I., Enkova V.V., Patlataya N.N., Sozykin A.A., Bedarev V.G., Zharov V.S.
A therapist-gynecologist alliance: a complex biologically active supplement with probiotic action for correcting intestinal biocenosis disorders
|
282-288 |
|
Dmitrievskaya M.I., Porfirova E.S., Tikhonenko P.A., Shchegortsova O.S.
Microbiome and depression: the impact of the microflora state on the treatment of depressive disorders
|
289-296 |